Medtronic plc
MDT-
Medtronic Plc. rose 0.2% to $90.04 after the medical device maker reported a marginal decline in profit in the fiscal first quarter ending on July 25.
Consolidated revenue in the quarter increased 8.4% to $8.6 billion from $7.9 billion, net income inched lower to $1.047 billion from $1.049 billion, and diluted earnings per share edged higher to 81 cents from 80 cents a year ago.
The company guided full-year revenue to rise between 6.5% and 6.8% and non-GAAP earnings per share to rise approximately 4.5% and range between $5.60 and $5.66.
Aug 20, 2025 -
Medtronic Plc. traded flat at $84.41 after the medical device provider reported higher revenue and earnings in the fourth quarter of 2025.
Net sales climbed to $8.93 billion from $8.59 billion, net income edged up to $1.06 billion from $654 million, and diluted earnings per share rose to 82 cents from 49 cents a year ago.
The medical technology company plans to separate its diabetes business into a standalone public company within 18 months.
The company announced a cash dividend of 71 cents per share, or an annual amount of $2.84 per share, payable on July 11 to shareholders on record on June 27.
Medtronic guided fiscal year 2026 organic revenue to grow by approximately 5%, compared to $33.54 billion, and diluted non-GAAP earnings per share to increase by 4%, compared to $5.49 a year earlier, respectively.
May 22, 2025 -
Medtronic Plc. gained 0.3% to $86.30 after the American-Irish medical device company reported results for the fiscal 2025 third quarter.
Revenue increased 2.5% to $8.29 billion from $8.09 billion, net income dropped to $1.29 billion from $1.32 billion, and diluted earnings per share rose to $1.01 from 99 cents a year ago.
Sales in the cardiovascular, medical surgical, and diabetes segments marked a steady growth in the quarter, while the neuroscience segment dropped 3.7% to $769 million from $799 million in the same period last year.
For the full year, Medtronic estimated non-GAAP earnings growth between 4.6% and 5.8% in the range of $5.44 to $5.50 per share.
Feb 19, 2025 -
Medtronic fiscal Q2 revenue fell 3.3% to $7.6 billion and net income plunged to $427 million from $1.3 billion or 32 cents from 97 cents a year ago.
Nov 22, 2022
|
|
| |
|
| Trading Volume | 162,626 |
|
|
89.35 - 69.43 |
| Market Cap Full | $ 117.2B |
Quarterly +
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Q1 | - | 1.3% | 5.7% | 3.6% |
| Q2 | - | - | -8.8% | 9.4% |
| Q3 | - | - | 9.8% | -11.1% |
| Q4 | - | - | -8.9% | 6% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2026 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | |||||||||||
| 1.3 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 6.2 | -4.8 | 4.5 | -8.8 | 2.4 | -2.5 | 1.2 | 9.8 | - | - | - | -7.5 |
| 2023 | |||||||||||
| 7.7 | -1.1 | -2.7 | 12.9 | -9 | 6.4 | -0.4 | -7.1 | -3.9 | -10 | 12.3 | 4 |
| 2022 | |||||||||||
| -0.6 | 1.5 | 5.7 | -5.4 | -4.9 | -10.1 | 3.2 | -5.1 | -8.2 | 8.2 | -9.5 | -1.7 |
| 2021 | |||||||||||
| -2.6 | 3.9 | 1 | 10.3 | -2.8 | -2 | 5.8 | 1.7 | -5.5 | -5 | -11 | -2.5 |
EPS
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Q1 | 0.9 | 1.1 | 0.9 |
| Q2 | 0.9 | 1.1 | 1 |
| Q3 | 0.6 | 0.7 | 0.6 |
| Q4 | 0.7 | 0.3 | 1 |
| A | 3.07 | 2.8 | 3.7 |